Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE GUILLEMAN : revenue, balance sheet and financial ratios

PHARMACIE GUILLEMAN is a French company founded 16 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ARPAJON (91290), this company of category PME shows in 2020 a net income positive of 159 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PHARMACIE GUILLEMAN (SIREN 512430703)
Kennzahl 2020 2019 2018 2017
Umsatz N/C N/C N/C N/C
Nettoergebnis 158 557 € 123 481 € 112 930 € 114 205 €
EBITDA N/C N/C N/C N/C
Nettomarge N/C N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2020, PHARMACIE GUILLEMAN generates positive net income of 159 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2020: 114 k€ -> 159 k€.

Nettoergebnis (2020) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

158 557 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 183%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 30%. The balance between equity and debt is satisfactory.

Verschuldungsgrad (2020) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

182.891%

Finanzielle Autonomie (2020) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

30.112%

Entwicklung der Solvenzkennzahlen
PHARMACIE GUILLEMAN

Positionnement sectoriel

Debt ratio
182.89 2020
2018
2019
2020
Q1: 33.22
Méd: 96.81
Q3: 238.41
Average -10 pts über 3 Jahre

In 2020, the debt ratio of PHARMACIE GUILLEMAN (182.89) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
30.11% 2020
2018
2019
2020
Q1: 23.59%
Méd: 41.65%
Q3: 61.93%
Average +7 pts über 3 Jahre

In 2020, the financial autonomy of PHARMACIE GUILLEMAN (30.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Positionnement de PHARMACIE GUILLEMAN dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 180 transactions of similar company sales in 2020, the value of PHARMACIE GUILLEMAN is estimated at 2 240 831 € (range 1 494 155€ - 3 023 487€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2020
180 transactions
1494k€ 2240k€ 3023k€
2 240 831 € Range: 1 494 155€ - 3 023 487€
NAF 5 année 2020

Valuation method used

Net Income Multiple
158 557 € × 14.1x = 2 240 832 €
Range: 1 494 155€ - 3 023 487€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE GUILLEMAN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE GUILLEMAN

What is the revenue of PHARMACIE GUILLEMAN ?

The revenue of PHARMACIE GUILLEMAN is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE GUILLEMAN profitable?

Yes, PHARMACIE GUILLEMAN generated a net profit of 159 k€ in 2020.

Where is the headquarters of PHARMACIE GUILLEMAN ?

The headquarters of PHARMACIE GUILLEMAN is located in ARPAJON (91290), in the department Essonne.

Where to find the tax return of PHARMACIE GUILLEMAN ?

The tax return of PHARMACIE GUILLEMAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE GUILLEMAN operate?

PHARMACIE GUILLEMAN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.